PNU-91356A
|  | |
| Clinical data | |
|---|---|
| ATC code | 
 | 
| Identifiers | |
| IUPAC name 
 | |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H17N3O | 
| Molar mass | 231.299 g·mol−1 | 
| 3D model (JSmol) | |
| SMILES 
 | |
| InChI 
 | |
PNU-91356A (U-91356) is a drug used in scientific research which acts as a potent and reasonably selective agonist of the dopamine receptor D2, with lower affinity for the related D3 and D4 subtypes and the 5-HT1A receptor.[1][2]
References
- ↑ Moon MW, Morris JK, Heier RF, Hsi RS, Manis MO, Royer ME, et al. (1993). "Medicinal chemistry of imidazoquinolinone dopamine receptor agonists". Drug Design and Discovery. 9 (3–4): 313–22. PMID 8104520.
- ↑ Piercey MF, Moon MW, Sethy VH, Schreur PJ, Smith MW, Tang AH, Von Voigtlander PF (December 1996). "Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype". European Journal of Pharmacology. 317 (1): 29–38. doi:10.1016/s0014-2999(96)00695-4. PMID 8982716.
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
